GovAI report makes nine recommendations for how AI providers assess and report biological risks under the EU AI Act

GovAI · Research report

Read the source (opens in a new tab)
What happened
GovAI published a technical report by Bhuvana Sudarshan, Zaheed Kara, Matthew van der Merwe, John Halstead and others on October 19, 2026, on managing biological risks from general-purpose AI models under the EU AI Act.
Key points
  • It says current requirements "grant providers considerable discretion over how biological risks are evaluated, documented, and communicated to the EU AI Office."
  • It finds biological risk evaluations hard to compare across providers, focused on standard deployment over contexts such as trusted access programs, and offering "limited visibility" into post-deployment monitoring.
  • Its priorities include evaluating trusted access deployments, incident reporting for biological risk, mapping capability thresholds to named responses, and reporting biological uplift in a standardized format.
  • The authors say some recommendations "depend on further action by the Office, such as new guidance or a revised Code."
Evidence
Policy research report from an AI governance research group, developed with experts in AI safety, governance and biosecurity. It makes recommendations and has no regulatory force.

See it in the latest record